Manufacturer of Controlled Substances; Notice of Registration; Alltech Associates, Inc., 23959 [2013-09531]

Download as PDF 23959 Federal Register / Vol. 78, No. 78 / Tuesday, April 23, 2013 / Notices interest at this time. DEA has investigated S & B Pharma Inc., to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems; verification of the company’s compliance with state and local laws; and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed. Dated: April 17, 2013. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2013–09532 Filed 4–22–13; 8:45 am] DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Registration; Alltech Associates, Inc. BILLING CODE 4410–09–P By Notice dated November 14, 2012 and published in the Federal Register on November 23, 2012, 77 FR 70188, Alltech Associates, Inc., 2051 Waukegan Road, Deerfield, Illinois 60015, made application to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the following basic classes of controlled substances: Drug Schedule 2C–T–2 (2-(4-Ethylthio-2,5-dimethoxyphenyl)ethanamine) (7385) ............................................................................................................. 2C–1 (2-(4-lodo-2,5-dimethoxyphenyl)ethanamine) (7518) ........................................................................................................................ 2C–C (2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (7519) ..................................................................................................................... The company plans to manufacture high purity drug standards used for analytical applications only in clinical, toxicological, and forensic laboratories. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Alltech Associates, Inc. to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Alltech Associates, Inc. to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR § 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed. Dated: April 16, 2013. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. mstockstill on DSK4VPTVN1PROD with NOTICES [FR Doc. 2013–09531 Filed 4–22–13; 8:45 am] BILLING CODE 4410–09–P VerDate Mar<15>2010 17:51 Apr 22, 2013 Jkt 229001 DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Registration; PCAS-Nanosyn, LLC By Notice dated January 15, 2013, and published in the Federal Register on January 30, 2013, 78 FR 6350, PCASNanosyn, LLC, 3331–B Industrial Drive, Santa Rosa, California 95403, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the following basic classes of controlled substances: Drug Schedule Amphetamine (1100) .................... Methamphetamine (1105) ............ Methylphenidate (1724) ................ Phencyclidine (7471) .................... Codeine (9050) ............................. Oxycodone (9143) ........................ Hydromorphone (9150) ................ Hydrocodone (9193) ..................... Methadone (9250) ........................ Morphine (9300) ........................... Oxymorphone (9652) ................... Fentanyl (9801) ............................ II II II II II II II II II II II II The company is a contract manufacturer. At the request of the company’s customers, it manufactures derivatives of controlled substances in bulk form only. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of PCAS-Nanosyn, LLC., to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has PO 00000 Frm 00077 Fmt 4703 Sfmt 4703 I I I investigated PCAS-Nanosyn, LLC., to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR § 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed. Dated: April 16, 2013. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2013–09529 Filed 4–22–13; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Registration; Cayman Chemical Company By Notice dated November 14, 2012, and published in the Federal Register on November 23, 2012, 77 FR 70188, Cayman Chemical Company, 1180 East Ellsworth Road, Ann Arbor, Michigan 48108, made application to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the following basic classes of controlled substances: E:\FR\FM\23APN1.SGM 23APN1

Agencies

[Federal Register Volume 78, Number 78 (Tuesday, April 23, 2013)]
[Notices]
[Page 23959]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-09531]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration; 
Alltech Associates, Inc.

    By Notice dated November 14, 2012 and published in the Federal 
Register on November 23, 2012, 77 FR 70188, Alltech Associates, Inc., 
2051 Waukegan Road, Deerfield, Illinois 60015, made application to the 
Drug Enforcement Administration (DEA) to be registered as a bulk 
manufacturer of the following basic classes of controlled substances:

 
------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
2C-T-2 (2-(4-Ethylthio-2,5-                   I
 dimethoxyphenyl)ethanamine) (7385).
2C-1 (2-(4-lodo-2,5-                          I
 dimethoxyphenyl)ethanamine) (7518).
2C-C (2-(4-Chloro-2,5-                        I
 dimethoxyphenyl)ethanamine (7519).
------------------------------------------------------------------------

    The company plans to manufacture high purity drug standards used 
for analytical applications only in clinical, toxicological, and 
forensic laboratories.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
Alltech Associates, Inc. to manufacture the listed basic classes of 
controlled substances is consistent with the public interest at this 
time. DEA has investigated Alltech Associates, Inc. to ensure that the 
company's registration is consistent with the public interest. The 
investigation has included inspection and testing of the company's 
physical security systems, verification of the company's compliance 
with state and local laws, and a review of the company's background and 
history.
    Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 
CFR Sec.  1301.33, the above named company is granted registration as a 
bulk manufacturer of the basic classes of controlled substances listed.

    Dated: April 16, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2013-09531 Filed 4-22-13; 8:45 am]
BILLING CODE 4410-09-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.